Furthermore, increased percentages of activated CD4, and even more so activated CD8 T cells, confirmed T-cell reactivity against myeloma cells and Balb/cJ cells among Allo-MM splenocytes (Fig.3 A). This evidence concerns the gene CD8A and Miyoshi myopathy.